Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
February 29 2024 - 7:00AM
Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call
on Wednesday, March 6, 2024, at 5:00 pm eastern time to discuss the
financial results for the fourth quarter and full year 2023.
Emergent’s newly appointed president and CEO, Joseph C. Papa, will
provide remarks.
Conference Call InformationParticipants can
access the conference call live via webcast from the Investors page
of Emergent’s website. To participate via telephone, please
register in advance at this link. Upon registration, all telephone
participants will receive a confirmation email detailing how to
join the conference call, including the dial-in number along with a
unique passcode and registrant ID that can be used to access the
call.
A replay of the call can be accessed from the Investors page of
Emergent’s website.
About Emergent BioSolutionsAt
Emergent, our mission is to protect and enhance life. For 25 years,
we’ve been at work defending people from things we hope will never
happen—so we are prepared just in case they ever do. We provide
solutions for complex and urgent public health threats through a
portfolio of vaccines and therapeutics that we develop and
manufacture for governments and consumers. We also offer a range of
integrated contract development and manufacturing services for
pharmaceutical and biotechnology customers. To learn more about how
we plan to protect or enhance 1 billion lives by 2030, visit
our website and follow us on LinkedIn, X
(formerly Twitter), and Instagram.
Investor Contact:Richard S.
LindahlExecutive Vice President, CFOlindahlr@ebsi.com
Media Contact:Assal HellmerVice
President, Communicationsmediarelations@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024